A collaborative approach to greater diversity in clinical trialsThe need for diversity in clinical trial populations has been a topic of discussion across regulators and the Share XA collaborative approach to greater diversity in clinical trialshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/a-collaborative-approach-to-greater-diversity-in-clinical-trials/
Company profile: EvideraData disruption and applying ‘enabled intelligence’ to convert the promise shown in clinical trials into real-world success. For Share XCompany profile: Eviderahttps://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/data-disruption-and-applying-enabled-intelligence/
Opening doors in pharmaceutical developmentEvidera surveys the adoption of machine learning by the pharmaceutical industry and looks at how it can increase Share XOpening doors in pharmaceutical developmenthttps://deep-dive.pharmaphorum.com/magazine/disruptive-technologies/machine-learning-opening-doors-in-pharmaceutical-development/
